James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY 14642, USA.
Department of Psychiatry and Human Behavior, Ponce Health Sciences University, Ponce, PR 00716, USA.
Int J Environ Res Public Health. 2021 Feb 3;18(4):1379. doi: 10.3390/ijerph18041379.
The purpose of this pilot study was to assess the feasibility and acceptability of a mobile smoking cessation intervention in Puerto Rico. This was a single-arm pilot study with 26 smokers in Puerto Rico who were enrolled in Decídetexto, a mobile smoking cessation intervention. Decídetexto incorporates three integrated components: (1) a tablet-based software that collects smoking-related information to develop an individualized quit plan, (2) a 24-week text messaging counseling program with interactive capabilities, and (3) pharmacotherapy support. Outcome measures included self-reported 7-day point prevalence abstinence at Months 3 and 6, pharmacotherapy adherence, satisfaction with the intervention, and changes in self-efficacy. The average age of the participants was 46.8 years (SD 12.7), half of them (53.8%) were female. Most participants (92.3%) smoked daily and half of them (53.8%) used menthol cigarettes. All participants requested nicotine patches at baseline. However, only 13.0% of participants used the patch >75% of days. At Month 3, 10 participants (38.4%) self-reported 7-day point prevalence abstinence (88.5% follow-up rate). At Month 6, 16 participants (61.5%) self-reported 7-day point prevalence abstinence (76.9% follow-up rate). Most participants (90%, 18/20) reported being satisfied/extremely satisfied with the intervention at Month 6. Self-efficacy mean scores significantly increased from 40.4 (SD 12.1) at baseline to 57.9 (SD 11.3) at Month 3 ( < 0.01). The study suggests that Decídetexto holds promise for further testing among Puerto Rican smokers.
本研究旨在评估在波多黎各实施一项移动戒烟干预措施的可行性和可接受性。这是一项单臂试点研究,共有 26 名波多黎各吸烟者参与了 Decídetexto 移动戒烟干预项目。Decídetexto 包含三个整合部分:(1)一个基于平板电脑的软件,用于收集与吸烟相关的信息,以制定个性化的戒烟计划;(2)一个为期 24 周的具有互动功能的短信咨询计划;(3)药物治疗支持。主要结局指标包括:(1)在第 3 个月和第 6 个月时,自我报告的 7 天点流行率(7-day point prevalence abstinence);(2)药物治疗的依从性;(3)对干预措施的满意度;(4)自我效能感的变化。参与者的平均年龄为 46.8 岁(标准差 12.7),其中一半(53.8%)为女性。大多数参与者(92.3%)每天吸烟,其中一半(53.8%)使用薄荷醇香烟。所有参与者在基线时都要求使用尼古丁贴片,但只有 13.0%的参与者在>75%的时间内使用了贴片。在第 3 个月时,有 10 名参与者(38.4%)自我报告了 7 天点流行率的戒烟(88.5%的随访率)。在第 6 个月时,有 16 名参与者(61.5%)自我报告了 7 天点流行率的戒烟(76.9%的随访率)。大多数参与者(90%,18/20)在第 6 个月时报告对干预措施感到满意/非常满意。自我效能感的平均得分从基线时的 40.4(标准差 12.1)显著增加到第 3 个月时的 57.9(标准差 11.3)(<0.01)。研究表明,Decídetexto 在波多黎各吸烟者中具有进一步测试的潜力。